InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,620.85
(
0.42%
)
US TECH 100
19,332.80
(
0.64%
)
Dow Jones
40,890.49
(
0.14%
)
Brent Oil
75.53
(
-0.21%
)
Bitcoin
60,657.52
(
2.80%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DB9

Send PM Follow Ignore
Followers 0
Posts 167
Boards Moderated 0
Alias Born 03/10/2007

DB9

Re: None

Saturday, 09/20/2008 8:52:40 AM

Saturday, September 20, 2008 8:52:40 AM

Post# of 19309
Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed
http://clinicaltrials.gov/ct2/show/NCT00170469?term=Anthrax&rank=2&flds=Xabco

PharmAthene UK Limited
This study has been completed.
Phase II


Last Updated
September 12, 2008





PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
http://www.genengnews.com/news/bnitem.aspx?name=41875418



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up